Long-term Delivery of Antiviral Monoclonal Antibodies

被引：0
|
作者：
Desrosiers, Ronald [1 ]
机构：
[1] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2018年 / 77卷
关键词：
D O I：
10.1097/01.qai.0000532589.29060.db
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C-102
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [21] Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk - No
    Tallantyre, Emma C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (08) : 1175 - 1177
  • [22] Long-term delivery of protein therapeutics
    Vaishya, Ravi
    Khurana, Varun
    Patel, Sulabh
    Mitra, Ashim K.
    EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (03) : 415 - 440
  • [23] LONG-TERM INTRAPERITONEAL INSULIN DELIVERY
    PITT, HA
    SAUDEK, CD
    ZACUR, HA
    ANNALS OF SURGERY, 1992, 216 (04) : 483 - 492
  • [24] Delivery and long-term expression of CCR5-blocking monoclonal antibody Leronlimab with AAV
    Wu, Helen L.
    Waytashek, Courtney M.
    Boyle, Carla D.
    Hwang, Joseph M.
    Fisher, Hannah K.
    Smedley, Jeremy V.
    Zikos, Joanna
    Magnani, Diogo M.
    Fuchs, Sebastian P.
    Desrosiers, Ronald C.
    Sacha, Jonah B.
    JOURNAL OF MEDICAL PRIMATOLOGY, 2023, 52 (05) : 334 - 334
  • [25] Antiviral therapy: Analysis of long-term efficacy and safety
    Te H.S.
    Current Hepatitis Reports, 2010, 9 (4) : 214 - 222
  • [26] Intracellular delivery of monoclonal antibodies
    Chen, BX
    Erlanger, BF
    IMMUNOLOGY LETTERS, 2002, 84 (01) : 63 - 67
  • [27] EFFECTS OF MONOCLONAL-ANTIBODIES ON EVOKED-POTENTIALS AND ON THE DEVELOPMENT OF LONG-TERM POSTTETANIC POTENTIATION OF THE HIPPOCAMPUS
    PANKOVA, TM
    STAROSTINA, MV
    LYUBOSLAVSKAYA, PN
    KHARCHENKO, VI
    SHTARK, MB
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1993, 116 (07) : 846 - 848
  • [28] Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: Commentary
    Lycke, Jan
    Svenningsson, Anders
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (08) : 1177 - 1178
  • [29] Long-Term Immunosuppression with Anti-CD25 Monoclonal Antibodies in Liver Transplant Patients.
    Cantarovich, M.
    Tchervenkov, J.
    Metrakos, P.
    Deschenes, M.
    Wong, P.
    Ghali, P.
    Chaudhury, P.
    Hassanain, M.
    Arena, G.
    Paraskevas, S.
    Barkun, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 689 - 689
  • [30] Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: YES
    Zecca, Chiara
    Gobbi, Claudio
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (08) : 1173 - 1175
12345